[Coronary spastic angina and it's associated diseases].
Nakayama
Masafumi
M
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto.
D000109:Acetylcholine / Q000502:physiology; D000788:Angina Pectoris, Variant / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001341:Autonomic Nervous System / Q000502:physiology; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002940:Circadian Rhythm; D003329:Coronary Vasospasm / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D017566:Microvascular Angina / Q000209:etiology; D009154:Mutation; D052250:Nitric Oxide Synthase Type III / Q000235:genetics; D012307:Risk Factors
D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D052250:Nitric Oxide Synthase Type III; D000109:Acetylcholine